Merck CEO sees faster production for cancer vaccine
CNBC · RSS · · AI-summarised by FinFlash
Merck's CEO told CNBC he expects the company's breakthrough cancer vaccine will become faster to make. His comments followed Merck's official opening of a new 120,000-square-foot research facility in the Greater Philadelphia area. The company is expanding its research footprint as it develops the vaccine.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.